Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Whitehawk Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +2 vs. Q2 2025
- Shares held
- 28.8M
- −601.7K (−2.0%) vs. Q2 2025
- Total value
- $54.3M
- −$267.5K (−0.5%) vs. Q2 2025
- New holders
- 5
- 5 more added
- Sold out
- 3
- 10 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 35 | $0 | 0.00% | +35 | New |
| Parallel Advisors, LLC | 8 | $15 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 19 | $36 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 46 | $87 | 0.00% | −365−88.8% | Reduced |
| BNP Paribas Arbitrage, SA | 160 | $304 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 232 | $443 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 386 | $733 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 421 | $800 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 797 | $1.51K | 0.00% | −3,301−80.6% | Reduced |
| Bartlett & Co. Wealth Management LLC | 1,333 | $2.53K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,849 | $3.51K | 0.00% | −154−7.7% | Reduced |
| Advisor Group Holdings, Inc. | 3,070 | $5.89K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 3,333 | $6.33K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,693 | $10.8K | 0.00% | −2,980−34.4% | Reduced |
| XTX Topco Ltd | 19,780 | $37.6K | 0.00% | +19,780 | New |
| Jane Street Group, LLC | 25,215 | $47.9K | 0.00% | −80,095−76.1% | Reduced |
| Acadian Asset Management LLC | 26,206 | $49.0K | 0.00% | +26,206 | New |
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $50.7K | 100.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 35,253 | $67.0K | 0.05% | +35,253 | New |
| Dimensional Fund Advisors LP | 44,115 | $83.8K | 0.00% | −26,634−37.6% | Reduced |
| State Street Corp | 68,737 | $130.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 72,164 | $137.1K | 0.00% | −20,111−21.8% | Reduced |
| Squarepoint Ops LLC | 83,660 | $159.0K | 0.00% | +22,294+36.3% | Added |
| Citadel Advisors LLC | 140,220 | $266.4K | 0.00% | +111,682+391.3% | Added |
| Bridgeway Capital Management, LLC | 215,284 | $409.0K | 0.01% | −100,000−31.7% | Reduced |
| BlackRock, Inc. | 296,158 | $562.7K | 0.00% | −2,162−0.7% | Reduced |
| Peapod Lane Capital LLC | 303,585 | $577.1K | 0.52% | +61,375+25.3% | Added |
| Geode Capital Management, LLC | 381,754 | $725.7K | 0.00% | +9,420+2.5% | Added |
| StemPoint Capital LP | 424,082 | $805.8K | 0.16% | +424,082 | New |
| Renaissance Technologies LLC | 457,422 | $869.1K | 0.00% | −800−0.2% | Reduced |
| Ally Bridge Group (NY) LLC | 817,939 | $1.55M | 1.30% | 00.0% | Unchanged |
| Acorn Capital Advisors, LLC | 1,139,363 | $2.16M | 1.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,342,907 | $2.55M | 0.00% | +27,622+2.1% | Added |
| Fan Yu | 2,070,000 | $3.93M | 5.12% | 00.0% | Unchanged |
| Siren, L.L.C. | 2,082,000 | $3.96M | 0.15% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 2,849,402 | $5.41M | 0.07% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 3,410,402 | $6.48M | 6.70% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,700,000 | $7.03M | 0.21% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,166,000 | $7.92M | 0.19% | 00.0% | Unchanged |
| QVT Financial LP | 4,615,709 | $8.33M | 0.92% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −1,091,417−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,103−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −358−100.0% | Sold out |